
Natco Pharma Limited has informed the Exchange regarding a press release dated July 26, 2023, titled "NATCO files generic Erdafitinib Tablets in USA".
Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated July 26, 2023, titled "NATCO files generic Erdafitinib Tablets in USA".
6ix hasn’t read this filing yet.
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma